DexCom (DXCM) PT Lowered to $105 at Oppenheimer; 'Buying on Weakness'
Tweet Send to a Friend
Oppenheimer analyst Steven Lichtman lowered the price target on DexCom (NASDAQ: DXCM) to $105.00 (from $525.00) while maintaining an Outperform ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
